|
Volumn 178, Issue 3, 2009, Pages 339-341
|
Management of refractory venous thrombosis associated with malignancy using a supra-therapeutic enoxaparin regimen
|
Author keywords
Cancer; Heparin; Venous thrombosis; Warfarin
|
Indexed keywords
BLOOD CLOTTING FACTOR 10A;
CARBOPLATIN;
CISPLATIN;
ENOXAPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
PACLITAXEL;
TINZAPARIN;
WARFARIN;
FIBRINOLYTIC AGENT;
ADULT;
ARTICLE;
BLEEDING;
CANCER RADIOTHERAPY;
CANCER STAGING;
CASE REPORT;
CAUSE OF DEATH;
CERVICAL LYMPH NODE;
COLPOSCOPY;
DEEP VEIN THROMBOSIS;
DISEASE ASSOCIATION;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
LUNG EMBOLISM;
LYMPH NODE BIOPSY;
LYMPH NODE METASTASIS;
METASTASIS POTENTIAL;
MULTIPLE CYCLE TREATMENT;
OVERALL SURVIVAL;
PATIENT MONITORING;
RADIATION DOSE FRACTIONATION;
RECURRENCE RISK;
TREATMENT OUTCOME;
UTERINE CERVIX CARCINOMA;
INTERNATIONAL NORMALIZED RATIO;
LYMPHATIC DISEASES;
PATHOLOGY;
SQUAMOUS CELL CARCINOMA;
TREATMENT FAILURE;
UTERINE CERVIX TUMOR;
VENOUS THROMBOSIS;
ADULT;
CARCINOMA, SQUAMOUS CELL;
ENOXAPARIN;
FEMALE;
FIBRINOLYTIC AGENTS;
HUMANS;
INTERNATIONAL NORMALIZED RATIO;
LYMPHATIC DISEASES;
TREATMENT FAILURE;
UTERINE CERVICAL NEOPLASMS;
VENOUS THROMBOSIS;
|
EID: 65349179456
PISSN: 00211265
EISSN: None
Source Type: Journal
DOI: 10.1007/s11845-008-0200-9 Document Type: Article |
Times cited : (6)
|
References (5)
|